Insider Trading › BBTX › Insiders
Bambusa Therapeutics, Inc.
BBTX·Nasdaq·
United States·Insider activity
$16.00
+0.45 (+2.89%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
BBTX
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
BBTXS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, BBTX insiders filed 5 purchases ($15.3M) and 0 sales ($0) on the open market, by 2 insiders. Newest filing Nov 3, 2026 (18 days ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by BBTX insiders · Form 4 · last two years
On Record
$15.3MPurchases · 180 days
$0Sales · 180 days
6Open-market transactions on record
2Insiders filing · 180 days
Purchases (code P) and sales (code S) of BBTX common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
6 on record · newest trade first · the newest 5 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund III, L.P. / Kolchinsky Peter / Shah Rajeev M.Director · Director | Purchase | +2.3M | n/c | — | 5.9Mindirect | Nov 2, 2026 | Nov 3, 2026 | Form 4 ↗ |
| RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund III, L.P. / Kolchinsky Peter / Shah Rajeev M.Director · Director | Purchase | +164.9K | $16.00 | $2.6M | 1.5Mindirect | Nov 2, 2026 | Nov 3, 2026 | Form 4 ↗ |
| Salvia Investment GmbH | Purchase | +375.0K | $16.00 | $6.0M | 9.3Mdirect | Nov 2, 2026 | Nov 2, 2026 | Form 4 ↗ |
| RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund III, L.P. / Kolchinsky Peter / Shah Rajeev M.Director · Director | Purchase | +263.9K | $14.92 | $3.9M | 453.8Kindirect | Oct 30, 2026 | Nov 3, 2026 | Form 4 ↗ |
| RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund III, L.P. / Kolchinsky Peter / Shah Rajeev M.Director · Director | Purchase | +189.9K | $14.23 | $2.7M | 189.9Kindirect | Oct 30, 2026 | Nov 3, 2026 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Sep 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →
